Assignee
MEDIMMUNE INC
US·34 granted patents·40 pending applications·2,546 citations·filing 1992–2008
Top patents by PatentIndex Score
74 records- 0199US7083784B2Molecules with extended half-lives, compositions and uses thereofMEDIMMUNE INC·Filed 2001·Granted Aug 1, 2006·704 cites·31 claims
- 0299US5824307AHuman-murine chimeric antibodies against respiratory syncytial virusMEDIMMUNE INC·Filed 1994·Granted Oct 20, 1998·343 cites·30 claims
- 0398US6818216B2Anti-RSV antibodiesMEDIMMUNE INC·Filed 2001·Granted Nov 16, 2004·165 cites·80 claims
- 0497US7229619B1Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE INC·Filed 2000·Granted Jun 12, 2007·114 cites·80 claims
- 0597US6656467B2Ultra high affinity neutralizing antibodiesMEDIMMUNE INC·Filed 2001·Granted Dec 2, 2003·96 cites·20 claims
- 0696US7294336B2Stabilized liquid anti-RSV antibody formulationsMEDIMMUNE INC·Filed 2006·Granted Nov 13, 2007·37 cites·60 claims
- 0796US7179900B2Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE INC·Filed 2003·Granted Feb 20, 2007·45 cites·80 claims
- 0896US7122194B2Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural motifsMEDIMMUNE INC·Filed 2003·Granted Oct 17, 2006·83 cites·10 claims
- 0996US6855493B2Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE INC·Filed 2001·Granted Feb 15, 2005·72 cites·73 claims
- 1096US6689369B2Immunogenic pneumococcal protein and vaccine compositions thereofMEDIMMUNE INC·Filed 2001·Granted Feb 10, 2004·71 cites·19 claims
- 1195US7323172B2Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE INC·Filed 2004·Granted Jan 29, 2008·48 cites·12 claims
- 1295US7297337B2EphA2 T-cell epitopes and uses thereforMEDIMMUNE INC·Filed 2005·Granted Nov 20, 2007·26 cites·45 claims
- 1395US7132100B2Stabilized liquid anti-RSV antibody formulationsMEDIMMUNE INC·Filed 2003·Granted Nov 7, 2006·49 cites·89 claims
- 1494US7425618B2Stabilized anti-respiratory syncytial virus (RSV) antibody formulationsMEDIMMUNE INC·Filed 2003·Granted Sep 16, 2008·55 cites·55 claims
- 1594US7354584B2Recombinant IL-9 antibodiesMEDIMMUNE INC·Filed 2004·Granted Apr 8, 2008·50 cites·9 claims
- 1694US6582706B1Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFSMEDIMMUNE INC·Filed 1999·Granted Jun 24, 2003·106 cites·11 claims
- 1793US6833356B1Pneumococcal protein homologs and fragments for vaccinesMEDIMMUNE INC·Filed 2000·Granted Dec 21, 2004·42 cites·8 claims
- 1893US6565849B2Methods of enhancing activity of vaccines and vaccine compositionsMEDIMMUNE INC·Filed 2001·Granted May 20, 2003·45 cites·19 claims
- 1987US7351533B2In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agentsMEDIMMUNE INC·Filed 2004·Granted Apr 1, 2008·27 cites·15 claims
- 2085US7435421B2Derivatives of choline binding proteins for vaccinesMEDIMMUNE INC·Filed 2005·Granted Oct 14, 2008·6 cites·6 claims
- 2184US7371383B2Recombinant anti-interleukin-9 antibodiesMEDIMMUNE INC·Filed 2003·Granted May 13, 2008·21 cites·44 claims
- 2284US6416945B1Vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPS)MEDIMMUNE INC·Filed 1999·Granted Jul 9, 2002·57 cites·9 claims
- 2383US5583038ABacterial expression vectors containing DNA encoding secretion signals of lipoproteinsMEDIMMUNE INC·Filed 1992·Granted Dec 10, 1996·98 cites·31 claims
- 2482US6962701B2Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune responseMEDIMMUNE INC·Filed 2003·Granted Nov 8, 2005·8 cites·13 claims
- 2582US6908613B2Chimeric human papillomavirus (HPV) L1 molecules and uses thereforMEDIMMUNE INC·Filed 2001·Granted Jun 21, 2005·21 cites·5 claims
- 2681US6887480B1Streptococcus pneumoniae proteins and vaccinesMEDIMMUNE INC·Filed 2000·Granted May 3, 2005·10 cites·9 claims
- 2780US6863893B2Derivatives of choline binding proteins for vaccinesMEDIMMUNE INC·Filed 2002·Granted Mar 8, 2005·10 cites·14 claims
- 2878US6737063B2FimH adhesin proteins and methods of useMEDIMMUNE INC·Filed 2001·Granted May 18, 2004·23 cites·4 claims
- 2974US6503511B1Derivatives of choline binding proteins for vaccinesMEDIMMUNE INC·Filed 1999·Granted Jan 7, 2003·27 cites·13 claims
- 3070US6261765B1In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs)MEDIMMUNE INC·Filed 1999·Granted Jul 17, 2001·23 cites·18 claims
- 3169US6500434B1Chaperone and adhesin proteins; vaccines, diagnostics and method for treating infectionsMEDIMMUNE INC·Filed 1999·Granted Dec 31, 2002·27 cites·37 claims
- 3267US7309490B2Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune responseMEDIMMUNE INC·Filed 2005·Granted Dec 18, 2007·0 cites·11 claims
- 3365US2005158342A1Multi plasmid system for the production of influenza virusMEDIMMUNE INC·Filed 2004·Application pending·0 cites
- 3464US2008096263A1Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial VirusMEDIMMUNE INC·Filed 2007·Application pending·0 cites
- 3564US2009053238A1Stabilized High Concentration Anti-Integrin alphavbeta3 Antibody FormulationsMEDIMMUNE INC·Filed 2006·Application pending·0 cites
- 3663US2007025990A1Methods of administering/dosing CD2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disordersMEDIMMUNE INC·Filed 2006·Application pending·0 cites
- 3763US2005147593A1EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disordersMEDIMMUNE INC·Filed 2004·Application pending·0 cites
- 3862US2005042664A1Humanization of antibodiesMEDIMMUNE INC·Filed 2004·Application pending·0 cites
- 3962US2008071063A1Protein FormulationsMEDIMMUNE INC·Filed 2007·Application pending·0 cites
- 4062US2007202122A1Non-splicing variants of gp350/220MEDIMMUNE INC·Filed 2006·Application pending·0 cites
- 4161US2009047277A1Recombinant il-9 antibodies and uses thereofMEDIMMUNE INC·Filed 2007·Application pending·0 cites
- 4260US5736367AVectors and prokaryotes which autocatalytically delete antibiotic resistanceMEDIMMUNE INC·Filed 1995·Granted Apr 7, 1998·27 cites·14 claims
- 4360US2004208870A1Stabilized high concentration anti-integrin alphanubeta3 antibody formulationsMEDIMMUNE INC·Filed 2004·Application pending·0 cites
- 4460US2009175883A1Stabilized anti-respiratory syncytial virus (RSV) antibody formulationsMEDIMMUNE INC·Filed 2008·Application pending·0 cites
- 4559US2010260749A1Modulators of EphA2 and Ephrin-A1 for the treatment of fibrosis-related diseaseMEDIMMUNE INC·Filed 2008·Application pending·0 cites
- 4658US2007092523A1Combination Therapy Of Respiratory Diseases Using AntibodiesMEDIMMUNE INC·Filed 2006·Application pending·0 cites
- 4757US2007166314A1EpA2 monoclonal antibodies and methods of use thereofMEDIMMUNE INC·Filed 2007·Application pending·0 cites
- 4856US2010278813A1Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodiesMEDIMMUNE INC·Filed 2007·Application pending·0 cites
- 4956US2006115485A1Methods of preventing and treating RSV infections and related conditionsMEDIMMUNE INC·Filed 2005·Application pending·0 cites
- 5055US2004208869A1Uses of anti-integrin alphanubeta3 antibody formulationsMEDIMMUNE INC·Filed 2004·Application pending·0 cites
Showing the top 50 of 74 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MEDIMMUNE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →